Syncom Formulations Share Price Target Forecast From 2025 To 2030

Pharmaceutical leader, Syncom Formulations (India) Ltd has got special recognition in developing and marketing bulk drugs and formulations for different therapeutic segments. The market cap stands at ₹1703 crores and as of 5th February 2025, the stocks are trading at ₹18.10.

In this short but interesting blog, we analyze the Syncom Formulations share price target from 2025 to 2030 based on current metrics, market trends, and expert forecasts.

Current Status of Syncom Formulations Share Price

Let’s take a look at the most recent performance summaries of Syncom Formulations:

• Open Price: ₹17.94
• Previous Close: ₹17.57
• Volume: 1,535,261 shares
• VWAP (Volume Weighted Average Price): ₹17.79
• Market Capitalization: ₹1,703 crore
• High: ₹18.10
• Low: ₹17.57
• 52 Week High: ₹27.90
• 52 Week Low: ₹11.00
• Face Value: ₹1
• All Time High: ₹27.90
• All Time Low: ₹7.25
• Book Value Per Share: ₹3.32

Currently, the stock price of Syncom Formulations is ₹18.10, which is showing a slight increase from the recent trading range. There is volatility in the stock price as indicated by the 52 week high of ₹27.90 and low of ₹11.00. Price fluctuations could be due to sentiments, trends, and other external factors.

Syncom Formulations Share Price Target Forecast

Taking into account the current market scenario and how well the company is doing financially, along with its growth possibilities, here is the projection of Syncom Formulations share price targets for 2025 to 2030:

Analysis of Syncom Formulations Share Price Targets

Syncom Formulations Share Price Target 2025 

In 2025, it is expected that the stock price of Syncom Formulations will be between ₹18.10 and ₹19.32. The following factors play a role in this growth:

• Product Portfolio Expansion: New pharmaceutical products will be launched to cater to the demand.

• Market Penetration: Existing markets will be expanded and new markets will be entered.

• Operatinal Efficiency: Manufacturing processes will be optimized to reduce cost.

Syncom Formulations Share Price Target 2026  

For the year 2026, the share price is expected to fall between ₹19.32 to ₹22.00, increase in the following factors are expected to drive the price up:

• Strategic Partnerships: Increased collaboration with other pharmaceutical companies for expanded product portfolios.

• Research and Development: Investments into R&D for additional healthcare products and services.

• Regulatory Approvals: Securing approval for new drug launches in local and international markets.

Syncom Formulations Share Price Target 2027  

These figures are expected to increase between ₹22.00 and ₹25.00 in 2027 owing to:

• Expansion Plan: Movement into associated segments of medicine like nutraceuticals.

• Emerging Markets: Increased export activity to developing countries.

• Reinforced Marketing: Greater brand marketing.

Looking for other promising stocks in the pharmaceutical sector? Cipla has shown impressive growth potential with strong fundamentals and a global presence. Read our complete guide on Cipla Share Price Target from 2025 to 2030 to explore future predictions, key growth factors, and market trends.

Syncom Formulations Share Price Target 2028  

In 2028, the value is projected to be between ₹25.00 and ₹28.00. The value will rise due to:

• Adoption of Novel Technologies: Increased utilization of modern production technology.

• Enhancement of Reputation: Adoption of green processes that are more sustainable.

• Industrial Loyalty: Creating loyalty through quality output.

Syncom Formulations Share Price Target 2029 

In 2029, these figures are expected to range between ₹28.00 and ₹32.00 due to:

• Entering New Markets: Development of presence in the more advanced international markets.

• Pharmaceuticals Development: More innovative pharmaceutical products are being developed.

• Marketing Excellence: High quality marketing and distribution of the products.

Syncom Formulations Share Price Target 2030 

By 2030, Syncom Formulations is estimated to reach between from ₹32.00 to ₹36.00. This increase will stem from:

• Dominance of Market: Growing and active pharma player in the market ensuring fruitful innovations.

• International Growth: Focusing on boosting exports and establishing alliances to enhance market penetration.

• Diversification: Targeting biotechnology, nutraceuticals, and specialty medicine markets with high profit margins.

• Sustained Revenue Growth: Continuous revenue and profit growth resulting from the increasing demand for the company’s products.

Revenue Structure for Syncom Formulations (Past Performance)

Syncom Formulations has shown a consistent picture of growth with their revenues demonstrating strong fundamentals over the years:

FY23: Revenue ₹464 crore | Net Profit ₹37 crore

FY24: Revenue ₹500 crore | Net Profit ₹42 crore

This growth momentum clearly demonstrates how Syncom Formulations is well positioned in the market to take advantage of the growing demand for healthcare and pharmaceuticals.

Key Factors Influencing Syncom Formulations' Share Price

Some of the factors that will drive the future share price of Syncom Formulations include:

• Growth of the Pharmaceutical Industry: Greater awareness for healthcare, higher purchase of low-cost medicines, and venturing into new diseases creates a positive outlook.

• Regulatory Approvals: Easing approval for new drugs can enhance the company’s revenue and market share.

• Geographical Expansion: The new emerging markets present an opportunity for rapid growth when expanding to new international markets.

• Innovation: Use of new methods of drug manufacturing and funding of research and development ensures competitiveness.

• Strategic Alliances: Merging with and acquiring foreign and local companies can result in higher sales and market share.

Risks and Challenges

Even though Syncom Formulations possesses significant potential for growth, some risks could lower its stock price:

Regulatory Hurdles: Compliance in government regulations for different countries is very strict.

Market Competition: Competition in the industry from established pharma companies can affect market share and pricing power.

Economic Slowdown: Healthcare spending, as well as the demand for medicines, could be negatively impacted due to an economic slowdown.

Raw Material Costs: Profits margins could be affected due to the change in prices of raw materials.

Operational Risks: Financial performance can be impacted by lack of efficiency in production, drug approvals, or changes in the supply chain.

FAQs on Syncom Formulations share price target 

Q:1 What is the projected Syncom Formulations share price in 2025?

A: For Syncom Formulations, the targeted share price in 2025 is estimated to be between ₹18.10 to ₹19.32, driven by expansion strategies, market demand, and financial performance.

Q:2 How does Syncom Formulation's shareholding pattern affect its stock performance?

A: A strong promoter holding ensures price stability while highly publicly owned shares can lead to volatility. Having a balance set up is crucial for share performance.

Q:3 What are the key factors driving Syncom Formulations’ growth?

A:

• Expansions into new regions.

• Investments in research and development.

• Forming new alliances.

• Increasing need for pharmaceutical services.

Q:4 Is Syncom Formulations a good investment?

A: Although Syncom Formulations has growth opportunities in the pharmaceutical industry, investors should be cautious about competition, regulations, and economic instability when making investment decisions.

Conclusion

With their robust market position, product advancement, and strategic growth revision, Syncom Formulations (India) Ltd. fuel growth and offers competitive opportunities. The stock price targets between 2025 to 2030 depict magnified growth prospects which makes the company handy for investors with a long-term view. However, investors should be aware of the market uncertainties and restrictions which have to be dealt with.